Period of time: 2004年2期
Publisher: Elsevier
Founded in: 2001
Total resources: 13
ISSN: 1473-3099
Subject: R5 Internal Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Lancet Infectious Diseases, The,volume 3,issue 2
Menu
Positive response to US smallpox vaccine policy
By Nierengarten M.B. in (2003)
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.Doubts cast on antimalarial drug
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.Ebola shows potential as a therapeutic tool
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.Value of the varicella vaccine
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.Success for river blindness control campaign
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.The genomics revolution has arrived in infectious diseases
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.vanA-mediated high level glycopeptide resistance in MRSA
By Gonzalez-Zorn B., Courvalin P. in (2003)
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.Epidemic meningococcal disease in sub-Saharan Africa-towards a sustainable solution?
By Pollard A.J., Maiden M.C.J. in (2003)
Lancet Infectious Diseases, The,volume 3,issue 2 , Vol. 3, Iss. 2, 2003-02 , pp.